Pro En Vimi Aureo-Sulfa-Vit 4.4 g Drug Premix is a Health Canada–registered veterinary drug (DIN 00765198) held by Unifeed, containing Chlortetracycline Hydrochloride. Health Canada lists its status as Cancelled Post Market (status date 02 Aug 2012). Nexara Health has matched 60 registrations of Chlortetracycline Hydrochloride across 7 other regulated markets.
Health Canada registration
| DIN | 00765198 |
|---|---|
| Brand name | Pro En Vimi Aureo-Sulfa-Vit |
| Active ingredient | Chlortetracycline Hydrochloride |
| Strength | 4.4 g |
| Dosage form | Drug Premix |
| Route | Oral |
| Company | Unifeed |
| Status | Cancelled Post Market — 02 Aug 2012 |
| Class | Veterinary |
| ATC | |
| AHFS | 38:00.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Chlortetracycline Hydrochloride registered in other markets
60 registrations of the same molecule in 7 national registries outside Canada (first 21 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Hong Kong | Chlortralim Eye Oint 1% | Atlantic Pharmaceutical Limited | Registered | DH Drug Office | ||
| Iceland | Animed vet. | aniMedica GmbH | 2,45 % w/w | húðúði | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Cyclospray | Eurovet Animal Health B.V. | 78,6 mg/g | húðúði | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Cyclospray vet. | Dýraheilsa- óskráð lyf | 2,4 % | húðúði | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Ophtaclin vet | Le Vet Beheer B.V. | 10 mg/g | augnsm | 0 | Lyfjastofnun lyfjaverdskra |
| MA | Aureomycine 1% | — | 1 % | Pommade Ophtalmique | G | CNOPS liste des medicaments |
| MA | Aureomycine 3% | — | 3 % | Pommade | G | CNOPS liste des medicaments |
| MA | Chlortetracycline Laprophan | — | 1 % | Pommade Ophtalmique | G | CNOPS liste des medicaments |
| MA | Chlortetracycline Laprophan | — | 3 % | Pommade | G | CNOPS liste des medicaments |
| Singapore | Chlortralim Ophthalmic Ointment 1% | Atlantic Pharmaceutical (S) Pte Ltd | 10 mg/g | Ointment | Prescription Only | HSA |
| Taiwan | Achromycin Powder | 臺灣氰胺股份有限公司新竹廠 | （粉） | 已註銷 | TFDA | |
| Taiwan | Aureomycin (Chlortetracycline Hydrochloride) Powder "Cyanamid" | 臺灣氰胺股份有限公司新竹廠 | （粉） | 已註銷 | TFDA | |
| Taiwan | Aureomycin Capsules 250mg | 臺灣惠氏股份有限公司新竹廠 | 膠囊劑 | 已註銷 | TFDA | |
| Taiwan | Aureomycin Ointment | 臺灣惠氏股份有限公司新竹廠 | 點眼膏劑 | 已註銷 | TFDA | |
| Taiwan | Aureomycin Ointment 30mg/g (Chlortetracycline) | 聯亞藥業股份有限公司新竹廠 | 軟膏劑 | Registered | TFDA | |
| Taiwan | Aureomycin Powder | 臺灣氰胺股份有限公司新竹廠 | （粉） | 已註銷 | TFDA | |
| Taiwan | Bromycin Capsules "Nysco" | 尼斯可股份有限公司新莊廠 | 膠囊劑 | 已註銷 | TFDA | |
| Taiwan | Capsulae Chlorteracyclin Hydrochloride "Y.y." | 應元化學製藥股份有限公司 | 膠囊劑 | 已註銷 | TFDA | |
| United Kingdom | Chlortetracycline 1% eye ointment | — | 0001 | NHS dm+d VMP | ||
| United States | Chlortetracycline | Inner Mongolia Shengxue Dacheng Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Chlortetracycline Hydrochloride | Fujian Fukang Pharmaceutical Co., Ltd | Powder | FDA NDC |
See every manufacturer of Chlortetracycline Hydrochloride worldwide →
Regulator price references for Chlortetracycline Hydrochloride
Published list or reimbursement prices for Chlortetracycline Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Ophtaclin vet | 10mg/1000mg | túpa | 923.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Cyclospray | 78.6mg/1000mg | úðaílá | 1,025.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Animed vet. | 2.45pct | úðaílá | 1,098.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Cyclospray vet. | 2.4pct | úðaílá | 1,266.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| MA | Chlortetracycline Laprophan | 1pct | 1 TUBE 5 G | 5.10 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Aureomycine 1% | 1pct | 1 TUBE 5 G | 5.50 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Chlortetracycline Laprophan | 3pct | 1 TUBE 15 G | 8.40 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Aureomycine 3% | 3pct | 1 TUBE 15 G | 9.30 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Pro En Vimi Aureo-Sulfa-Vit (DIN 00765198) marketed in Canada?
No. Health Canada lists DIN 00765198 as Cancelled Post Market as of 02 Aug 2012.
Who holds the Canadian licence for this product?
Unifeed is the company of record in the Health Canada Drug Product Database.
Is Chlortetracycline Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 60 registrations in 7 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00765198, status date 2012-08-02; national medicine registries: CNOPS liste des medicaments, DH Drug Office, FDA NDC, HSA, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, TFDA; price sources: CNOPS liste des medicaments, Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00765198, status date 2012-08-02; national medicine registries: CNOPS liste des medicaments, DH Drug Office, FDA NDC, HSA, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, TFDA; price sources: CNOPS liste des medicaments, Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 00765198, status date 2012-08-02; national medicine registries: CNOPS liste des medicaments, DH Drug Office, FDA NDC, HSA, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, TFDA; price sources: CNOPS liste des medicaments, Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.